Cargando…

Strategies for adaptation of mAb-producing CHO cells to serum-free medium

Detalles Bibliográficos
Autores principales:	Costa, A Rita, Rodrigues, M Elisa, Henriques, Mariana, Oliveira, Rosário, Azeredo, Joana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284978/ https://www.ncbi.nlm.nih.gov/pubmed/22373295 http://dx.doi.org/10.1186/1753-6561-5-S8-P112

Ejemplares similares

Preliminary evaluation of microcarrier culture for growth and monoclonal antibody production of CHO-K1 cells
por: Rodrigues, M Elisa, et al.
Publicado: (2011)

Novel strategy for a high-yielding mAb-producing CHO strain (overexpression of non-coding RNA enhanced proliferation and improved mAb yield)
por: Tabuchi, Hisahiro
Publicado: (2013)

How to assess chemically defined media and feeds from 9 suppliers on CHO cells producing mAb
por: Polès-Lahille, Aurore, et al.
Publicado: (2013)

Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells
por: Nematpour, Fatemeh, et al.
Publicado: (2017)

Adaptation of glucocerebrosidase-producing CHO cells to serum-free suspension culture
por: Novo, Juliana Branco, et al.
Publicado: (2014)

A Single Dynamic Metabolic Model Can Describe mAb Producing CHO Cell Batch and Fed-Batch Cultures on Different Culture Media
por: Robitaille, Julien, et al.
Publicado: (2015)

Quantitative definition and monitoring of the host cell protein proteome using iTRAQ – a study of an industrial mAb producing CHO‐S cell line
por: Chiverton, Lesley M., et al.
Publicado: (2016)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

Increased mAb production in amplified CHO cell lines is associated with increased interaction of CREB1 with transgene promoter
por: Dahodwala, Hussain, et al.
Publicado: (2019)

Medium and feed optimization for fed-batch production of a monoclonal antibody in CHO cells
por: Kochanowski, Nadine, et al.
Publicado: (2011)

Development of a chemically defined CHO medium by engineering based on a feed solution
por: Landauer, Karlheinz, et al.
Publicado: (2011)

Novel human partner cell line for immortalisation of rare antigen-specific B cells in mAb development
por: Kaseko, Galina, et al.
Publicado: (2011)

Transient gene expression with CHO cells in conditioned medium: a study using TubeSpin(®) bioreactors
por: Pereira, João, et al.
Publicado: (2011)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb
por: Kim, Deuk-Su, et al.
Publicado: (2016)

The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Cellular tools for biosimilar mAb analysis
por: Lindemann, Carsten, et al.
Publicado: (2013)

Evolving trends in mAb production processes
por: Shukla, Abhinav A., et al.
Publicado: (2017)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

A neutralizing monoclonal antibody (mAb A24) directed against the transferrin receptor induces apoptosis of tumor T lymphocytes from ATL patients
por: Moura, Ivan C, et al.
Publicado: (2011)

Anti-HER2 mAb plus calicheamicin immunoconjugate linked on liposomal vinorelbine induces ADCC and apoptosis in HER2-positive high grade DCIS
por: Giannos, J, et al.
Publicado: (2000)

Effect of iron sources on the glycosylation macroheterogeneity of human recombinant IFN-γ produced by CHO cells during batch processes
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

Comparison of the activity and pluripotency maintaining potential of human leukemia inhibitory factor (LIF) produced in E.coli and CHO cells
por: Haake, Claas, et al.
Publicado: (2011)

Production and purification of TGFb-1 in CHO-Cells
por: Abdulkerim, Estabraq, et al.
Publicado: (2011)

Engineering CHO cell metabolism for growth in galactose
por: Jiménez, Natalia E, et al.
Publicado: (2011)

Next-generation sequencing of the CHO cell transcriptome
por: Becker, Jennifer, et al.
Publicado: (2011)

Stability enhancement in a mAb and Fab coformulation
por: Zhang, Hongyu, et al.
Publicado: (2020)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

A mAb for the detection of the antiretroviral drug emtricitabine
por: Youngpairoj, Ae S., et al.
Publicado: (2022)

The impact of microcarrier culture optimization on the glycosylation profile of a monoclonal antibody
por: Costa, Ana Rita, et al.
Publicado: (2013)

Bioreactor cultivation of CHO DP-12 cells under sodium butyrate treatment – comparative transcriptome analysis with CHO cDNA microarrays
por: Klausing, Sandra, et al.
Publicado: (2011)

CHO cell lines generated by PiggyBac transposition
por: Matasci, Mattia, et al.
Publicado: (2011)

Engineering CHO cells for improved central carbon and energy metabolism
por: Wilkens, Camila A, et al.
Publicado: (2011)

Study of a recombinant CHO cell line producing a monoclonal antibody by ATF or TFF external filter perfusion in a WAVE Bioreactor™
por: Clincke, Marie-Françoise, et al.
Publicado: (2011)

Targets for MAbs: innovative approaches for their discovery & validation, LabEx MAbImprove 6(th) antibody industrial symposium, June 25-26, 2018, Montpellier, France
por: Martineau, Pierre, et al.
Publicado: (2019)

Analysis of glycolytic flux as a rapid screen to identify low lactate producing CHO cell lines with desirable monoclonal antibody yield and glycan profile
por: Legmann, Rachel, et al.
Publicado: (2011)

Single use bioreactors for the clinical production of monoclonal antibodies – a study to analyze the performance of a CHO cell line and the quality of the produced monoclonal antibody
por: Diekmann, Sonja, et al.
Publicado: (2011)

A mAb against surface-expressed FSHR engineered to engage adaptive immunity for ovarian cancer immunotherapy
por: Bordoloi, Devivasha, et al.
Publicado: (2022)

LDH-C can be differentially expressed during fermentation of CHO cells
por: Szperalski, Berthold, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ep14isar8tud5899a82frtr77j